Strategic Consensus on a Proposed Vaccination Schedule for Adults in Portugal
DOI:
https://doi.org/10.20344/amp.23273Keywords:
Adult, Immunization Programs, Immunization Schedule, Portugal, VaccinationAbstract
n/a.
Downloads
References
Bloom DE, Zucker LM. Aging is the real population bomb. 2023. [cited 2025 Mar 25]. Available from: https://www.imf.org/en/Publications/fandd/issues/Series/Analytical-Series/aging-is-the-real-population-bomb-bloom-zucker.
Doherty TM, Del Giudice G, Maggi S. Adult vaccination as part of a healthy lifestyle: moving from medical intervention to health promotion. Ann Med. 2019;51:128-40.
World Health Organization. Vaccines and immunization. 2025. [cited 2025 Mar 25]. Available from: https://www.who.int/health-topics/vaccines-and-immunization#tab=tab_1.
Boschiero MN, Palamim CV, Camargo TM, Marson FA. The rise of old villains: the vaccination downfall worldwide. Pulmonology. 2025;31:2466924.
Supporting Active Ageing Through Immunisation (SAATI) Partnership. Adult vaccination: a key component of healthy ageing : the benefits of life-course immunisation in Europe. 2013. [cited 2025 Mar 25]. Available from: https://ilcuk.org.uk/wp-content/uploads/2018/11/Adult-vaccination_a-key-component-of-health-ageing.pdf.
Paget J, Danielle Iuliano A, Taylor RJ, Simonsen L, Viboud C, Spreeuwenberg P. Estimates of mortality associated with seasonal influenza for the European Union from the GLaMOR project. Vaccine. 2022;40:1361-9.
van Oorschot D, Vroling H, Bunge E, Diaz-Decaro J, Curran D, Yawn B. A systematic literature review of herpes zoster incidence worldwide. Hum Vaccin Immunother. 2021;17:1714-32.
Tavabe NR, Kheiri S, Dehghani M, Mohammadian-Hafshejani A. A systematic review and meta-analysis of the relationship between receiving the flu vaccine with acute cerebrovascular accident and its hospitalization in the elderly. Biomed Res Int. 202313;2023:2606854.
Wu X, Yang H, He S, Xia T, Chen D, Zhou Y, et al. Adult vaccination as a protective factor for dementia: a meta-analysis and systematic review of population-based observational studies. Front Immunol. 2022;13:872542.
European Centre for Disease Prevention and Control. Vaccine scheduler. 2025. [cited 2025 Mar 23]. Available from: https://vaccine-schedule.ecdc.europa.eu/Scheduler/ByCountry?SelectedCountryId=167&IncludeChildAgeGroup=true&IncludeAdultAgeGroup=true&SelectedVersionId=56.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Acta Médica Portuguesa
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All the articles published in the AMP are open access and comply with the requirements of funding agencies or academic institutions. The AMP is governed by the terms of the Creative Commons ‘Attribution – Non-Commercial Use - (CC-BY-NC)’ license, regarding the use by third parties.
It is the author’s responsibility to obtain approval for the reproduction of figures, tables, etc. from other publications.
Upon acceptance of an article for publication, the authors will be asked to complete the ICMJE “Copyright Liability and Copyright Sharing Statement “(http://www.actamedicaportuguesa.com/info/AMP-NormasPublicacao.pdf) and the “Declaration of Potential Conflicts of Interest” (http:// www.icmje.org/conflicts-of-interest). An e-mail will be sent to the corresponding author to acknowledge receipt of the manuscript.
After publication, the authors are authorised to make their articles available in repositories of their institutions of origin, as long as they always mention where they were published and according to the Creative Commons license.
